USD 7.34
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 4.73 Billion CNY | -1.7% |
2022 | 4.92 Billion CNY | 35.03% |
2021 | 3.65 Billion CNY | 23.81% |
2020 | 2.94 Billion CNY | 23.2% |
2019 | 2.39 Billion CNY | 31.02% |
2018 | 1.82 Billion CNY | 22.99% |
2017 | 1.48 Billion CNY | 18.54% |
2016 | 1.25 Billion CNY | 6.07% |
2015 | 1.18 Billion CNY | 42.34% |
2014 | 829.83 Million CNY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 1.04 Billion CNY | -26.57% |
2024 Q3 | 1.14 Billion CNY | 49.78% |
2024 Q2 | 1.1 Billion CNY | 5.75% |
2023 Q2 | 1.04 Billion CNY | -8.53% |
2023 FY | 4.84 Billion CNY | -1.7% |
2023 Q1 | 1.14 Billion CNY | -17.25% |
2023 Q3 | 1.23 Billion CNY | 18.08% |
2023 Q4 | 1.42 Billion CNY | 15.99% |
2022 Q3 | 1.38 Billion CNY | 21.52% |
2022 Q1 | 1.01 Billion CNY | -8.24% |
2022 FY | 4.92 Billion CNY | 35.03% |
2022 Q2 | 1.14 Billion CNY | 12.05% |
2022 Q4 | 1.37 Billion CNY | -0.71% |
2021 FY | 3.65 Billion CNY | 23.81% |
2021 Q4 | 1.11 Billion CNY | 23.68% |
2021 Q2 | 852.35 Million CNY | 8.13% |
2021 Q1 | 788.27 Million CNY | -8.51% |
2021 Q3 | 898.51 Million CNY | 5.42% |
2020 Q2 | 765.32 Million CNY | 32.28% |
2020 Q1 | 578.58 Million CNY | -19.75% |
2020 Q3 | 742.88 Million CNY | -2.93% |
2020 FY | 2.94 Billion CNY | 23.2% |
2020 Q4 | 861.6 Million CNY | 15.98% |
2019 Q4 | 720.94 Million CNY | 16.84% |
2019 Q2 | 556.16 Million CNY | 11.43% |
2019 Q1 | 499.09 Million CNY | -10.56% |
2019 FY | 2.39 Billion CNY | 31.02% |
2019 Q3 | 617.01 Million CNY | 10.94% |
2018 Q1 | 337.27 Million CNY | -5.09% |
2018 FY | 1.82 Billion CNY | 22.99% |
2018 Q2 | 401.88 Million CNY | 19.16% |
2018 Q4 | 558.01 Million CNY | 5.39% |
2018 Q3 | 529.48 Million CNY | 31.75% |
2017 FY | 1.48 Billion CNY | 18.54% |
2017 Q4 | 355.35 Million CNY | -17.02% |
2017 Q3 | 428.23 Million CNY | 38.37% |
2017 Q1 | 315.29 Million CNY | 0.0% |
2017 Q2 | 309.47 Million CNY | -1.84% |
2016 FY | 1.25 Billion CNY | 6.07% |
2015 FY | 1.18 Billion CNY | 42.34% |
2014 FY | 829.83 Million CNY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
American Bio Medica Corporation | 1.04 Million USD | -451732.348% |
Arrayit Corporation | 6.19 Million USD | -76377.018% |
Atlantic International Corp. | 5.57 Million USD | -84867.509% |
Biocept, Inc. | 29.4 Million USD | -16020.953% |
Bioqual, Inc. | 7.44 Million USD | -63530.918% |
CardioGenics Holdings Inc | 772.14 Thousand USD | -613740.632% |
DermTech, Inc. | 104.01 Million USD | -4456.767% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | -2746.658% |
HTG Molecular Diagnostics, Inc. | 22.62 Million USD | -20850.265% |
iMD Companies, Inc. | 151.8 Thousand USD | -3122060.96% |
IDenta Corp. | 662.97 Thousand USD | -714817.053% |
Interpace Biosciences, Inc. | 20.23 Million USD | -23326.855% |
Integrative Health Technologies, Inc. | 38.88 Thousand USD | -12190227.749% |
InVitro International | 661.32 Thousand USD | -716601.848% |
Lumos Diagnostics Holdings Limited | 7.09 Million USD | -66675.448% |
Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -8156083.46% |
Medical Imaging Corp. | 1.91 Million USD | -247772.114% |
NovelStem International Corp. | 3.53 Million USD | -133873.731% |
Optigenex Inc. | 1.28 Million USD | -367928.218% |
PharmChem, Inc. | 2.93 Million USD | -161597.409% |
Proteome Sciences plc | 3.26 Million USD | -144934.312% |
Response Genetics, Inc | 25.31 Million USD | -18620.018% |
Rennova Health, Inc. | 7.67 Million USD | -61632.926% |
RushNet, Inc. | 1.78 Million USD | -264789.53% |
ScreenPro Security Inc. | 3.23 Million USD | -146236.791% |
Stella Diagnostics Inc. | 11.42 Million USD | -41378.446% |
StageZero Life Sciences Ltd. | 7.34 Million USD | -64447.338% |
Todos Medical Ltd. | 14.05 Million USD | -33615.474% |